A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms Article (Web of Science)

Open Access Industry Collaboration International Collaboration

cited authors

  • Wolin, Edward; Mita, Alain; Mahipal, Amit; Meyer, Tim; Bendell, Johanna; Nemunaitis, John; Munster, Pam N.; Paz-Ares, Luis; Filvaroff, Ellen H.; Li, Shaoyi; Hege, Kristen; de Haan, Hans; Mita, Monica

publication date

  • September 17, 2019

webpage

published in

category

volume

  • 14

issue

  • 9